Wang, Y. (2018). Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationWang, Y. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationWang, Y. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.